Addex Therapeutics
ADXN | NASDAQ
$3.83
-$0.23 (-5.67%)
At close: Nov 16, 2026, 4:00 PM ET
$3.72
-$0.11 (-2.87%)
After-hours:
Nov 16, 2026, 7:27 PM ET
-5.67%
(1D)No price chart data available for 1D timeframe.
Rating
30
+1.5 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #790/1021 (Top 77%)
Key Statistics
Market Data
Market Cap $5.57M
1D Range
3.60 3.99
52W Range
2.65 8.99
Valuation (TTM)
PE -0.54
PB 2.36
EV/EBITDA -0.67
Valuation (NTM)
Forward PE N/A
Forward PEG 0.02
Price Target $30.00
Cash Flow
FCF Yield -50.8%
SBC Adj. FCF Yield -51.3%
SBC Impact -1.0%
Margins
Gross Margin 41.2%
Operating Margin -5460.8%
FCF Margin -4994.9%
Growth (CAGR)
Revenue 3Y | 5Y -71.8% |
-58.1%
Dil EPS 3Y | 5Y -161.6% |
69.9%
FCF 3Y | 5Y 70.2% |
47.9%
Returns
ROA -197.6%
ROE -172.8%
ROIC -120.0%
Financial Health
Net Cash
CHF767.33K ($949.28K)
Current Ratio 0.76
Interest Coverage -138.34
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting ...
Sector Healthcare
Industry Biotechnology
Employees 3
IPO Date Feb 12, 2020
Website www.addextherapeutics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove ADXN